https://doi.org/10.4081/cardio.2024.46

Prognostic factors and outcome in patients submitted into coronary artery bypass surgery with total arterial myocardial revascularization

Vol. 2 No. 4 (2024)
Published: December 30, 2024
total arterial myocardial revascularization, TAMR, coronary artery disease, coronary artery bypass grafting
Abstract Views: 179
PDF: 59
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Elias Tassoulas
Euroclinic hospital of Athens, Greece.
Dimitrios Tasoulas
2nd Cardiology Department, General Hospital of Nikea, Piraeus, Greece.
Christos Papaconstantinou
Emeritus Professor of Cardiac Surgery, AHEPA Hospital, Thessaloniki, Greece.
Ioannis Chlorogiannis
Consultant Cardiac Surgeon and Director of Cardiac Surgery Department in Athens Euroclinic Hospital, Athens, Greece.

Background: Coronary artery bypass grafting relieves symptoms and improves survival in patients with severe coronary artery disease. Large series and meta-analyses show that total arterial myocardial revascularization (TAMR) may offer additional survival benefit. The primary objective of this study was to investigate long-term (>5 years) survival of patients undergoing TAMR. The change in coronary artery disease risk factors during the follow-up period was also evaluated.
Methods: Forty patients undergoing coronary artery bypass grafting (CABG) with total arterial myocardial revascularization (TAMR) were studied. All patients were screened for coronary artery disease risk factors at entry and follow-up. Repeat coronary angiography at a 5-year follow-up was used to investigate the long-term patency of arterial grafts.
Results: Mean patient EuroSCORE was 1.42±1.1%. Mean follow-up time was 9.3±4.8 years (range: 1 month to 15.6 years). The 30-day mortality was 2.5% (1/40 patients), while the 12-month mortality was 7.5% (3/40 patients) with an actual survival of 92.5%. The 5-year and 10-year mortality was 15.8% (6/38 patients) and 33.3% (10/30 patients) respectively, while actual survival reached 84.2% and 66.7% at 5 and 10 years respectively. A total of 10/40 patients (25%) died during follow-up. Mean time-to-event was 3.5±2.7 years (range: one month to 7.1 years); 40% of deaths occurred during the first 2 years from the procedure, and 40% occurred during the period from 4.5 to 6.5 years post-surgery. The main cause of death was cerebrovascular disease in 30% of patients, while 20% died of cancer. 40% of fatalities were cardiac-related but not due to ischemic heart disease. The incidence of major adverse cardiac and cerebrovascular events (a composite outcome of cardiac-related death, myocardial infarction, need for revascularization and stroke) was 17.5% during follow-up. Total morbidity reached 30%. The use of the radial artery resulted in a similar survival to the use of bilateral internal mammary arteries exclusively. The numbers of grafts used were 39 Left internal mammary artery grafts (LIMA), 34 right internal mammary artery grafts (RIMA) and 24 right radial artery grafts (RAD). Repeat coronary angiography at a 5-year follow-up revealed that all arterial grafts were patent. Control of arterial hypertension (blood pressure <30/80 mmHg) was achieved in 65% of patients postoperatively compared to 22.5% preoperatively (p=0.01).
Conclusions: TAMR is safe and effective with encouraging results in terms of long-term survival. This is the first reported study investigating long-term outcomes in patients undergoing total arterial revascularization in Greece.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
1. Collins P, Webb CM, Chong CF, et al. Radial artery versus saphenous vein patency (RSVP) trial investigators. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation 2008, 117: 2859–64.
2. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012;33:1635–701.
3. Weiss AJ, Zhao S, Tian DH, et al. A meta-analysis comparing bilateral internal mammary artery with left internal mammary artery for coronary artery bypass grafting. Ann Cardiothorac Surg 2013, 2: 390-400.
4. Kollosof VI. Mammary artery – coronary artery anastomosis as method of treatment of angina pectoris. J Thorac Cardiovascu Surg. 1970; 60:469482.
5. Lytle BW, Blackstone EH, Sabik JF, et al. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg 2004, 78: 2005-12. DOI: https://doi.org/10.1016/j.athoracsur.2004.05.070
6. Damgaard S, Steinbrόchel DA, Kjaergard HK. An update on internal mammary artery grafting for coronary artery disease. Curr Opin Cardiol 2005, 20: 521-4. DOI: https://doi.org/10.1097/01.hco.0000182833.26273.f1
7. Taggart DP, Altman DG, Gray AM, et al. Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1year results of the Arterial Revascularization Trial (ART). Eur Heart J 2010, 31: 2470-81. DOI: https://doi.org/10.1093/eurheartj/ehq318
8. Dimitrova KR, Hoffman DM, Geller CM, et al. Arterial grafts protect the native coronary vessels from atherosclerotic disease progression. Ann Thorac Surg 2012, 94: 475-81. DOI: https://doi.org/10.1016/j.athoracsur.2012.04.035
9. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts—effects on survival over a 15-year period. N Engl J Med 1996, 334: 216-9. DOI: https://doi.org/10.1056/NEJM199601253340402
10. Puskas JD, Kilgo PD, Kutner M, et al. Off-pump techniques disproportionately benefit women and narrow the gender disparity in outcomes after coronary artery bypass surgery. Circulation 2007, 116: I192-9. DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.678979
11. Lytle BW. Bilateral internal thoracic artery grafting. Ann Cardiothorac Surg 2013, 2: 485-92.
12. Galbut DL, Kurlansky PA, Traad EA, et al. Bilateral internal thoracic artery grafting improves longterm survival in patients with reduced ejection fraction: a propensity- matched study with 30-year follow-up. J Thorac Cardiovasc Surg 2012, 143: 844-53. DOI: https://doi.org/10.1016/j.jtcvs.2011.12.026
13. Popovic B, Voillot D, Maureira P, et al. Bilateral internal mammary artery bypass grafting: long-term clinical benefits in a series of 1000 patients. Heart 2013, 99: 854-9. DOI: https://doi.org/10.1136/heartjnl-2012-303466
14. Tatoulis J, Buxton BF, Fuller JA. The right internal thoracic artery: the forgotten conduit—5,766 patients and 991 angiograms. Ann Thorac Surg 2011, 92: 9-15. DOI: https://doi.org/10.1016/j.athoracsur.2011.03.099
15. Tsuneyoshi H, Komiya T, Shimamoto T, et al. The second best arterial graft to the left coronary system in off-pump bypass surgery: a propensity analysis of the radial artery with a proximal anastomosis to the ascending aorta versus the right internal thoracic artery. Gen Thorac Cardiovasc Surg. 2015;63(6):335-42. DOI: https://doi.org/10.1007/s11748-015-0534-y
16. Schwann TA, Hashim SW, Badour S, et al. Equipoise between radial artery and right internal thoracic artery as the second arterial conduit in left internal thoracic artery-based coronary artery bypass graft surgery: a multi-institutional study. Eur J Cardiothorac Surg. 2016;49(1):188-95. DOI: https://doi.org/10.1093/ejcts/ezv093
17. Deb S, Cohen EA, Singh SK, Une D, Laupacis A, Fremes SE; RAPS Investigators. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol. 2012 Jul 3;60(1):28-35. doi: 10.1016/j.jacc.2012.03.037. PMID: 22742399 DOI: https://doi.org/10.1016/j.jacc.2012.03.037
18. Collins P, Webb CM, Chong CF, Moat NE; Radial Artery Versus Saphenous Vein Patency (RSVP) Trial Investigators. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation. 2008 Jun 3;117(22):2859-64. doi: 10.1161/CIRCULATIONAHA.107.736215. Epub 2008 May 27. PMID: 18506009. DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.736215
19. Buxton, Brian F. et al. Radial artery patency and clinical outcomes: five-year interim results of a randomized trial. The Journal of Thoracic and Cardiovascular Surgery, Volume 125, Issue 6, 1363 – 1370 DOI: https://doi.org/10.1016/S0022-5223(02)73241-8
20. Kinoshita T, Asai T, Murakami Y, et al. Efficacy of bilateral internal thoracic artery grafting in patients with chronic kidney disease. Ann Thorac Surg 2010; 89: 1106-11 DOI: https://doi.org/10.1016/j.athoracsur.2009.12.025
21. Medalion B, Mohr R, Frid O, et al. Should bilateral internal thoracic artery grafting be used in elderly patients undergoing coronary artery bypass grafting? Circulation 2013; 127: 2186-93. DOI: https://doi.org/10.1161/CIRCULATIONAHA.112.001330
22. Toumpoulis IK, Theakos N, Dunning J. Does bilateral internal thoracic artery harvest increase the risk of mediastinitis? Interact Cardiovasc Thorac Surg 2007; 6: 787-91. DOI: https://doi.org/10.1510/icvts.2007.164343
23. Effect of total arterial grafting in the Arterial Revascularization Trial, Randomized Controlled Trial J Thorac Cardiovasc Surg 2022 Mar;163(3):1002-1009.e6 DOI: https://doi.org/10.1016/j.jtcvs.2020.03.013
24. Saphenous Vein Graft Failure after Coronary Artery Bypass Surgery: Insights from PREVENT IV Hess CN, Lopes RD, Gibson CM, et al. The publisher's final edited version of this article is available free at Circulation See commentary "Response to Letters re: Saphenous Vein Graft Failure after Coronary Artery Bypass Surgery" in Circulation, volume 132 on page e29. See other articles in PMC that cite the published article.

How to Cite

Tassoulas, E., Tasoulas, D., Papaconstantinou, C., & Chlorogiannis, I. (2024). Prognostic factors and outcome in patients submitted into coronary artery bypass surgery with total arterial myocardial revascularization. Global Cardiology, 2(4). https://doi.org/10.4081/cardio.2024.46
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.


Similar Articles

<< < 1 2 3 4 > >> 

You may also start an advanced similarity search for this article.